

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.53370193 |
| 2 | neuronal action potential propagation (GO:0019227) | 6.07365165 |
| 3 | cerebellar granule cell differentiation (GO:0021707) | 6.06927101 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.80835084 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.68664216 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.66217723 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.55977430 |
| 8 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.47693675 |
| 9 | gamma-aminobutyric acid transport (GO:0015812) | 5.38456918 |
| 10 | cerebellar Purkinje cell differentiation (GO:0021702) | 5.29865903 |
| 11 | short-term memory (GO:0007614) | 5.26438277 |
| 12 | cellular potassium ion homeostasis (GO:0030007) | 5.26428782 |
| 13 | vocalization behavior (GO:0071625) | 5.15044874 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 5.12579797 |
| 15 | sodium ion export (GO:0071436) | 5.10004117 |
| 16 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.05190442 |
| 17 | response to pheromone (GO:0019236) | 4.98563393 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 4.97114962 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.86541585 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.79755224 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 4.75046167 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.68419217 |
| 23 | long-term memory (GO:0007616) | 4.68414484 |
| 24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.63766034 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.54184313 |
| 26 | cerebellar Purkinje cell layer development (GO:0021680) | 4.47289003 |
| 27 | glutamate secretion (GO:0014047) | 4.46652930 |
| 28 | cell differentiation in hindbrain (GO:0021533) | 4.44655892 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.44341794 |
| 30 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.41978451 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 4.35778359 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 4.28632042 |
| 33 | exploration behavior (GO:0035640) | 4.26249671 |
| 34 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.25355772 |
| 35 | neuromuscular process controlling balance (GO:0050885) | 4.24919507 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.24128912 |
| 37 | neuromuscular process controlling posture (GO:0050884) | 4.13315881 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.11967755 |
| 39 | regulation of synaptic vesicle transport (GO:1902803) | 4.11344616 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.10008337 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.08396365 |
| 42 | prepulse inhibition (GO:0060134) | 4.07593393 |
| 43 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.02064819 |
| 44 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.00313474 |
| 45 | layer formation in cerebral cortex (GO:0021819) | 3.93826859 |
| 46 | metanephric nephron tubule development (GO:0072234) | 3.90508981 |
| 47 | metanephric tubule development (GO:0072170) | 3.90508981 |
| 48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.88790125 |
| 49 | positive regulation of muscle hypertrophy (GO:0014742) | 3.87221972 |
| 50 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.87221972 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.84644786 |
| 52 | potassium ion import (GO:0010107) | 3.83548695 |
| 53 | regulation of postsynaptic membrane potential (GO:0060078) | 3.80747988 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.76200868 |
| 55 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.74310413 |
| 56 | response to histamine (GO:0034776) | 3.72689656 |
| 57 | neurotransmitter transport (GO:0006836) | 3.70695640 |
| 58 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.70606222 |
| 59 | membrane depolarization during action potential (GO:0086010) | 3.67976443 |
| 60 | cell communication by electrical coupling (GO:0010644) | 3.62664536 |
| 61 | auditory behavior (GO:0031223) | 3.62239634 |
| 62 | activation of protein kinase A activity (GO:0034199) | 3.59794487 |
| 63 | C4-dicarboxylate transport (GO:0015740) | 3.59723652 |
| 64 | glycine transport (GO:0015816) | 3.58910071 |
| 65 | metanephric nephron epithelium development (GO:0072243) | 3.57807371 |
| 66 | long term synaptic depression (GO:0060292) | 3.57755926 |
| 67 | regulation of neurotransmitter levels (GO:0001505) | 3.56568194 |
| 68 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.54833472 |
| 69 | dendritic spine morphogenesis (GO:0060997) | 3.52953316 |
| 70 | protein localization to synapse (GO:0035418) | 3.52818375 |
| 71 | relaxation of cardiac muscle (GO:0055119) | 3.50983296 |
| 72 | regulation of ARF protein signal transduction (GO:0032012) | 3.50941520 |
| 73 | cellular sodium ion homeostasis (GO:0006883) | 3.49054211 |
| 74 | adult walking behavior (GO:0007628) | 3.47665107 |
| 75 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.47225463 |
| 76 | membrane depolarization (GO:0051899) | 3.46985386 |
| 77 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.42011866 |
| 78 | serotonin metabolic process (GO:0042428) | 3.38704387 |
| 79 | negative regulation of hormone metabolic process (GO:0032351) | 3.36208941 |
| 80 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.36208941 |
| 81 | regulation of neurotransmitter secretion (GO:0046928) | 3.35363464 |
| 82 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.35130722 |
| 83 | establishment of nucleus localization (GO:0040023) | 3.34398585 |
| 84 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.31748275 |
| 85 | relaxation of smooth muscle (GO:0044557) | 3.31031654 |
| 86 | regulation of synaptic plasticity (GO:0048167) | 3.30482615 |
| 87 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.30334526 |
| 88 | synaptic vesicle endocytosis (GO:0048488) | 3.29857898 |
| 89 | membrane hyperpolarization (GO:0060081) | 3.29571461 |
| 90 | mechanosensory behavior (GO:0007638) | 3.28998522 |
| 91 | potassium ion homeostasis (GO:0055075) | 3.28857117 |
| 92 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28775691 |
| 93 | dendrite morphogenesis (GO:0048813) | 3.27533140 |
| 94 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.26802983 |
| 95 | neuromuscular process (GO:0050905) | 3.24888160 |
| 96 | metanephric epithelium development (GO:0072207) | 3.24766927 |
| 97 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.24174700 |
| 98 | regulation of synapse maturation (GO:0090128) | 3.24048760 |
| 99 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.23972506 |
| 100 | detection of calcium ion (GO:0005513) | 3.19986461 |
| 101 | regulation of neurotransmitter transport (GO:0051588) | 3.17370038 |
| 102 | long-term synaptic potentiation (GO:0060291) | 3.17175357 |
| 103 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16905512 |
| 104 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.15515296 |
| 105 | amino acid import (GO:0043090) | 3.14632538 |
| 106 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.12579089 |
| 107 | neurofilament cytoskeleton organization (GO:0060052) | 3.11665976 |
| 108 | fructose metabolic process (GO:0006000) | 3.09335361 |
| 109 | chemosensory behavior (GO:0007635) | 3.08063121 |
| 110 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.07047774 |
| 111 | collecting duct development (GO:0072044) | 3.06760552 |
| 112 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.04507061 |
| 113 | acidic amino acid transport (GO:0015800) | 3.02381799 |
| 114 | response to auditory stimulus (GO:0010996) | 3.02211500 |
| 115 | proline transport (GO:0015824) | 2.98602595 |
| 116 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.98581579 |
| 117 | mating behavior (GO:0007617) | 2.98311515 |
| 118 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.97812147 |
| 119 | L-amino acid import (GO:0043092) | 2.97335894 |
| 120 | positive regulation of dendritic spine development (GO:0060999) | 2.96770645 |
| 121 | relaxation of muscle (GO:0090075) | 2.94779956 |
| 122 | negative regulation of heart contraction (GO:0045822) | 2.94633735 |
| 123 | regulation of vesicle fusion (GO:0031338) | 2.93742211 |
| 124 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93565377 |
| 125 | synapse assembly (GO:0007416) | 2.93491388 |
| 126 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.91853050 |
| 127 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.90537114 |
| 128 | synaptic transmission (GO:0007268) | 2.89853800 |
| 129 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.87355999 |
| 130 | neuron cell-cell adhesion (GO:0007158) | 2.85818263 |
| 131 | primary amino compound metabolic process (GO:1901160) | 2.84145640 |
| 132 | negative regulation of fatty acid transport (GO:2000192) | 2.80036694 |
| 133 | cellular response to ammonium ion (GO:0071242) | 2.79162193 |
| 134 | cGMP metabolic process (GO:0046068) | 2.77843565 |
| 135 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.76109166 |
| 136 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.74348173 |
| 137 | retina layer formation (GO:0010842) | 2.72199422 |
| 138 | regulation of synaptic transmission (GO:0050804) | 2.71060098 |
| 139 | sodium ion homeostasis (GO:0055078) | 2.70088772 |
| 140 | endocrine hormone secretion (GO:0060986) | 2.69689695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.66600374 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.26492512 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.15259928 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.95551555 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.86331225 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86127870 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.84651122 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.84651122 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79073175 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.75202211 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65484119 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.60276848 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.59791653 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.58154266 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54496471 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48685242 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45633191 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42892700 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.34715292 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27828913 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.22685046 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19643453 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.19485586 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14064080 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11087838 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06633868 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05868705 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.88580352 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85340729 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81957228 |
| 31 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.81765275 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61818672 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61605844 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.56677513 |
| 35 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.52906518 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49947170 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48292256 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47370607 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46636981 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44809033 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44278508 |
| 42 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44159714 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41262043 |
| 44 | AR_19668381_ChIP-Seq_PC3_Human | 1.38881420 |
| 45 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37151714 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34839013 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.32435089 |
| 48 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31196053 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30588924 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30041383 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29871813 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27408401 |
| 53 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25979511 |
| 54 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25444583 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23388111 |
| 56 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23302993 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22613734 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19343332 |
| 59 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19260697 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18442242 |
| 61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18315794 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.17649735 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17342840 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15667822 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15472558 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15391497 |
| 67 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15284927 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12686131 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10888460 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09949301 |
| 71 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09811008 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09491230 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08619129 |
| 74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07490740 |
| 75 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.06699507 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06636792 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06596985 |
| 78 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04627137 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04500188 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04458650 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03486876 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03405878 |
| 83 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02885731 |
| 84 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02766690 |
| 85 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02685849 |
| 86 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01160215 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00654063 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00025524 |
| 89 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99666965 |
| 90 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99090058 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99005564 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98783436 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98710259 |
| 94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98627891 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98346081 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98187261 |
| 97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97743757 |
| 98 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97696468 |
| 99 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97085095 |
| 100 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96759778 |
| 101 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96200029 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95707146 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94786858 |
| 104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94651160 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94495464 |
| 106 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94128526 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94103982 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93913033 |
| 109 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93853468 |
| 110 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92707502 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91362079 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90852825 |
| 113 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90808822 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90580839 |
| 115 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90492551 |
| 116 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90352530 |
| 117 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90016120 |
| 118 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89952691 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89886773 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89601231 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88822769 |
| 122 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87841661 |
| 123 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87800006 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86880966 |
| 125 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83408687 |
| 126 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82134479 |
| 127 | P300_19829295_ChIP-Seq_ESCs_Human | 0.80905232 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80158772 |
| 129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80077948 |
| 130 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.76430381 |
| 131 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.75818120 |
| 132 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75771916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.79289647 |
| 2 | * MP0003635_abnormal_synaptic_transmissio | 4.41609547 |
| 3 | * MP0009046_muscle_twitch | 4.38917722 |
| 4 | MP0009745_abnormal_behavioral_response | 3.63797694 |
| 5 | MP0004270_analgesia | 3.37394138 |
| 6 | MP0003880_abnormal_central_pattern | 3.32430834 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.27234193 |
| 8 | * MP0002064_seizures | 3.26009467 |
| 9 | MP0002272_abnormal_nervous_system | 3.17286246 |
| 10 | MP0002822_catalepsy | 3.13217574 |
| 11 | * MP0008569_lethality_at_weaning | 3.10257674 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.89884186 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.85802355 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.84958169 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.63241745 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.58895153 |
| 17 | MP0001486_abnormal_startle_reflex | 2.55595844 |
| 18 | MP0004145_abnormal_muscle_electrophysio | 2.47643725 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.41251675 |
| 20 | * MP0002067_abnormal_sensory_capabilities | 2.34028129 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.33071041 |
| 22 | MP0002736_abnormal_nociception_after | 2.10001813 |
| 23 | MP0002184_abnormal_innervation | 2.07318261 |
| 24 | MP0002909_abnormal_adrenal_gland | 2.00050823 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.94224640 |
| 26 | MP0005386_behavior/neurological_phenoty | 1.90286010 |
| 27 | MP0004924_abnormal_behavior | 1.90286010 |
| 28 | MP0001970_abnormal_pain_threshold | 1.83791808 |
| 29 | MP0003329_amyloid_beta_deposits | 1.82901123 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.82447423 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.81694832 |
| 32 | MP0004885_abnormal_endolymph | 1.81124135 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.74453362 |
| 34 | MP0003879_abnormal_hair_cell | 1.62521974 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.62398408 |
| 36 | MP0003633_abnormal_nervous_system | 1.60934319 |
| 37 | MP0004142_abnormal_muscle_tone | 1.58580577 |
| 38 | MP0000955_abnormal_spinal_cord | 1.54950047 |
| 39 | * MP0002066_abnormal_motor_capabilities/c | 1.54507561 |
| 40 | MP0004147_increased_porphyrin_level | 1.47987286 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.46605321 |
| 42 | MP0003631_nervous_system_phenotype | 1.43636530 |
| 43 | MP0003632_abnormal_nervous_system | 1.42482421 |
| 44 | MP0004742_abnormal_vestibular_system | 1.29743318 |
| 45 | MP0008872_abnormal_physiological_respon | 1.28786330 |
| 46 | MP0004858_abnormal_nervous_system | 1.28436323 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.27970997 |
| 48 | MP0003690_abnormal_glial_cell | 1.27636192 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.26469537 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.26288955 |
| 51 | MP0001984_abnormal_olfaction | 1.22856507 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.21946764 |
| 53 | MP0000778_abnormal_nervous_system | 1.21595962 |
| 54 | MP0004043_abnormal_pH_regulation | 1.21272869 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.14858400 |
| 56 | MP0003283_abnormal_digestive_organ | 1.13745480 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11341858 |
| 58 | MP0000920_abnormal_myelination | 1.10559276 |
| 59 | MP0008874_decreased_physiological_sensi | 1.09936570 |
| 60 | * MP0002152_abnormal_brain_morphology | 1.07784328 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.05937134 |
| 62 | MP0002009_preneoplasia | 1.03602136 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.03001877 |
| 64 | MP0004215_abnormal_myocardial_fiber | 1.01101147 |
| 65 | MP0001177_atelectasis | 1.00331418 |
| 66 | MP0003045_fibrosis | 0.99200620 |
| 67 | MP0003303_peritoneal_inflammation | 0.99132176 |
| 68 | MP0002229_neurodegeneration | 0.96189875 |
| 69 | MP0006276_abnormal_autonomic_nervous | 0.95487442 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.94397226 |
| 71 | MP0004084_abnormal_cardiac_muscle | 0.94115720 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.92931236 |
| 73 | MP0001188_hyperpigmentation | 0.92135327 |
| 74 | MP0003137_abnormal_impulse_conducting | 0.90727682 |
| 75 | MP0002069_abnormal_eating/drinking_beha | 0.87177498 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.86885405 |
| 77 | MP0003075_altered_response_to | 0.86473213 |
| 78 | MP0004130_abnormal_muscle_cell | 0.85439293 |
| 79 | MP0004510_myositis | 0.84805218 |
| 80 | MP0004085_abnormal_heartbeat | 0.84257471 |
| 81 | MP0000604_amyloidosis | 0.83836197 |
| 82 | MP0000751_myopathy | 0.82310755 |
| 83 | MP0005535_abnormal_body_temperature | 0.82186107 |
| 84 | MP0003787_abnormal_imprinting | 0.79239159 |
| 85 | MP0004484_altered_response_of | 0.79018935 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.78327742 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.76599106 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.76403056 |
| 89 | MP0005409_darkened_coat_color | 0.72520671 |
| 90 | MP0004233_abnormal_muscle_weight | 0.71999962 |
| 91 | MP0001299_abnormal_eye_distance/ | 0.70777580 |
| 92 | MP0008057_abnormal_DNA_replication | 0.70315081 |
| 93 | MP0001851_eye_inflammation | 0.70024985 |
| 94 | MP0005166_decreased_susceptibility_to | 0.68119382 |
| 95 | MP0003634_abnormal_glial_cell | 0.67851980 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.66523172 |
| 97 | MP0005187_abnormal_penis_morphology | 0.65173499 |
| 98 | MP0005671_abnormal_response_to | 0.63415054 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.63341153 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.63296094 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.62740358 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.62456080 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.62299704 |
| 104 | * MP0002083_premature_death | 0.60394831 |
| 105 | * MP0010769_abnormal_survival | 0.60382428 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.60308540 |
| 107 | MP0003646_muscle_fatigue | 0.59305184 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.58333503 |
| 109 | * MP0010768_mortality/aging | 0.57135295 |
| 110 | MP0005083_abnormal_biliary_tract | 0.55660153 |
| 111 | MP0000747_muscle_weakness | 0.54340668 |
| 112 | MP0005620_abnormal_muscle_contractility | 0.54299906 |
| 113 | * MP0002082_postnatal_lethality | 0.53801535 |
| 114 | * MP0010770_preweaning_lethality | 0.53801535 |
| 115 | MP0003868_abnormal_feces_composition | 0.53267209 |
| 116 | MP0002166_altered_tumor_susceptibility | 0.52135466 |
| 117 | MP0005310_abnormal_salivary_gland | 0.52008396 |
| 118 | * MP0003956_abnormal_body_size | 0.51385446 |
| 119 | MP0005387_immune_system_phenotype | 0.51279698 |
| 120 | MP0001790_abnormal_immune_system | 0.51279698 |
| 121 | MP0003866_abnormal_defecation | 0.50812535 |
| 122 | MP0001943_abnormal_respiration | 0.50576551 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.50349548 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.49054154 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.49024450 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.47824016 |
| 127 | MP0004036_abnormal_muscle_relaxation | 0.47561792 |
| 128 | MP0002090_abnormal_vision | 0.46150374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.38024117 |
| 2 | Myokymia (HP:0002411) | 7.22574772 |
| 3 | Progressive cerebellar ataxia (HP:0002073) | 6.66626450 |
| 4 | Visual hallucinations (HP:0002367) | 6.03286587 |
| 5 | Focal seizures (HP:0007359) | 5.96311721 |
| 6 | Atonic seizures (HP:0010819) | 4.95920908 |
| 7 | Febrile seizures (HP:0002373) | 4.83232568 |
| 8 | * Gaze-evoked nystagmus (HP:0000640) | 4.67727180 |
| 9 | * Action tremor (HP:0002345) | 4.59581763 |
| 10 | Hemiplegia (HP:0002301) | 4.56347308 |
| 11 | Annular pancreas (HP:0001734) | 4.24674585 |
| 12 | Absence seizures (HP:0002121) | 4.19103150 |
| 13 | Epileptic encephalopathy (HP:0200134) | 4.16380594 |
| 14 | Poor eye contact (HP:0000817) | 4.06284796 |
| 15 | Genetic anticipation (HP:0003743) | 4.04957667 |
| 16 | Abnormality of the lower motor neuron (HP:0002366) | 3.81820618 |
| 17 | * Dysdiadochokinesis (HP:0002075) | 3.72344949 |
| 18 | Abnormal social behavior (HP:0012433) | 3.71371283 |
| 19 | Impaired social interactions (HP:0000735) | 3.71371283 |
| 20 | Dialeptic seizures (HP:0011146) | 3.66134028 |
| 21 | * Dysmetria (HP:0001310) | 3.65556307 |
| 22 | Tetraplegia (HP:0002445) | 3.62519831 |
| 23 | * Impaired smooth pursuit (HP:0007772) | 3.61422286 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 3.60137263 |
| 25 | Hemiparesis (HP:0001269) | 3.57458335 |
| 26 | Status epilepticus (HP:0002133) | 3.51824578 |
| 27 | Depression (HP:0000716) | 3.51127415 |
| 28 | Abnormality of binocular vision (HP:0011514) | 3.50753905 |
| 29 | Diplopia (HP:0000651) | 3.50753905 |
| 30 | * Abnormality of ocular smooth pursuit (HP:0000617) | 3.50667706 |
| 31 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.46557940 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.46557940 |
| 33 | * Intention tremor (HP:0002080) | 3.27840872 |
| 34 | Anxiety (HP:0000739) | 3.26919296 |
| 35 | Neurofibrillary tangles (HP:0002185) | 3.10685190 |
| 36 | Ventricular fibrillation (HP:0001663) | 3.08526000 |
| 37 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.06011585 |
| 38 | Postural instability (HP:0002172) | 2.99842312 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.90357013 |
| 40 | * Broad-based gait (HP:0002136) | 2.84402816 |
| 41 | Stereotypic behavior (HP:0000733) | 2.80678787 |
| 42 | Bundle branch block (HP:0011710) | 2.77754691 |
| 43 | * Truncal ataxia (HP:0002078) | 2.72113894 |
| 44 | Pointed chin (HP:0000307) | 2.68746175 |
| 45 | Supranuclear gaze palsy (HP:0000605) | 2.67791916 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.67627027 |
| 47 | Lower limb asymmetry (HP:0100559) | 2.66896393 |
| 48 | Ankle clonus (HP:0011448) | 2.63528392 |
| 49 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.58238537 |
| 50 | Agitation (HP:0000713) | 2.47885647 |
| 51 | Spastic gait (HP:0002064) | 2.47744596 |
| 52 | Papilledema (HP:0001085) | 2.42349685 |
| 53 | Spinal canal stenosis (HP:0003416) | 2.41540205 |
| 54 | Impaired vibratory sensation (HP:0002495) | 2.38111890 |
| 55 | Torticollis (HP:0000473) | 2.35310351 |
| 56 | Mutism (HP:0002300) | 2.34374147 |
| 57 | Resting tremor (HP:0002322) | 2.31065577 |
| 58 | Focal dystonia (HP:0004373) | 2.30801861 |
| 59 | Lower limb muscle weakness (HP:0007340) | 2.29714804 |
| 60 | Neuronal loss in central nervous system (HP:0002529) | 2.27458210 |
| 61 | Amyotrophic lateral sclerosis (HP:0007354) | 2.26504020 |
| 62 | Bradykinesia (HP:0002067) | 2.22537835 |
| 63 | * Abnormality of saccadic eye movements (HP:0000570) | 2.20425542 |
| 64 | Autoamputation (HP:0001218) | 2.18178019 |
| 65 | Drooling (HP:0002307) | 2.17165887 |
| 66 | Excessive salivation (HP:0003781) | 2.17165887 |
| 67 | Hyperventilation (HP:0002883) | 2.16594173 |
| 68 | Insidious onset (HP:0003587) | 2.15683012 |
| 69 | Termporal pattern (HP:0011008) | 2.15683012 |
| 70 | Clonus (HP:0002169) | 2.14294065 |
| 71 | Abnormality of the corticospinal tract (HP:0002492) | 2.14083615 |
| 72 | Incomplete penetrance (HP:0003829) | 2.12504535 |
| 73 | * Gait ataxia (HP:0002066) | 2.12194997 |
| 74 | Global brain atrophy (HP:0002283) | 2.09713986 |
| 75 | Urinary urgency (HP:0000012) | 2.09538524 |
| 76 | Megalencephaly (HP:0001355) | 2.07929770 |
| 77 | Obstructive sleep apnea (HP:0002870) | 2.07850319 |
| 78 | Psychosis (HP:0000709) | 2.07419457 |
| 79 | Abnormality of the periventricular white matter (HP:0002518) | 2.02255806 |
| 80 | Epileptiform EEG discharges (HP:0011182) | 2.01106768 |
| 81 | Spastic tetraparesis (HP:0001285) | 2.00712751 |
| 82 | Increased circulating renin level (HP:0000848) | 1.99188084 |
| 83 | EEG with generalized epileptiform discharges (HP:0011198) | 1.98360176 |
| 84 | Myotonia (HP:0002486) | 1.98319824 |
| 85 | * Limb ataxia (HP:0002070) | 1.97955844 |
| 86 | Fetal akinesia sequence (HP:0001989) | 1.97746609 |
| 87 | Confusion (HP:0001289) | 1.97712504 |
| 88 | Slow saccadic eye movements (HP:0000514) | 1.94548000 |
| 89 | Amblyopia (HP:0000646) | 1.93245176 |
| 90 | * Horizontal nystagmus (HP:0000666) | 1.92040546 |
| 91 | Distal upper limb amyotrophy (HP:0007149) | 1.91903628 |
| 92 | Upper limb amyotrophy (HP:0009129) | 1.91903628 |
| 93 | Hypsarrhythmia (HP:0002521) | 1.91253886 |
| 94 | Short chin (HP:0000331) | 1.91211257 |
| 95 | Craniofacial dystonia (HP:0012179) | 1.89116584 |
| 96 | Neoplasm of the heart (HP:0100544) | 1.88123364 |
| 97 | * Dysmetric saccades (HP:0000641) | 1.88101116 |
| 98 | Absent speech (HP:0001344) | 1.87378990 |
| 99 | Oligodactyly (hands) (HP:0001180) | 1.83912527 |
| 100 | Prolonged QT interval (HP:0001657) | 1.83036681 |
| 101 | Memory impairment (HP:0002354) | 1.82152731 |
| 102 | Abnormal EKG (HP:0003115) | 1.81792689 |
| 103 | Aqueductal stenosis (HP:0002410) | 1.81770158 |
| 104 | Ocular albinism (HP:0001107) | 1.80634932 |
| 105 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.79644103 |
| 106 | Progressive inability to walk (HP:0002505) | 1.78071523 |
| 107 | Apathy (HP:0000741) | 1.76777153 |
| 108 | Hand muscle atrophy (HP:0009130) | 1.74194128 |
| 109 | Insomnia (HP:0100785) | 1.72978773 |
| 110 | * Scanning speech (HP:0002168) | 1.72432323 |
| 111 | * Slow progression (HP:0003677) | 1.72307035 |
| 112 | Macroorchidism (HP:0000053) | 1.71785342 |
| 113 | Iris hypopigmentation (HP:0007730) | 1.71304636 |
| 114 | Rigidity (HP:0002063) | 1.70939944 |
| 115 | Hypoplastic nipples (HP:0002557) | 1.69390772 |
| 116 | Syncope (HP:0001279) | 1.65741544 |
| 117 | * Dysarthria (HP:0001260) | 1.62163557 |
| 118 | Paraplegia (HP:0010550) | 1.57882592 |
| 119 | Diminished motivation (HP:0000745) | 1.57157776 |
| 120 | Athetosis (HP:0002305) | 1.56989758 |
| 121 | Hyperlipoproteinemia (HP:0010980) | 1.53014154 |
| 122 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.49745684 |
| 123 | Lower limb amyotrophy (HP:0007210) | 1.49295916 |
| 124 | Rapidly progressive (HP:0003678) | 1.47974996 |
| 125 | Spastic paraplegia (HP:0001258) | 1.47513252 |
| 126 | Relative macrocephaly (HP:0004482) | 1.47460101 |
| 127 | Colitis (HP:0002583) | 1.46648546 |
| 128 | * Postural tremor (HP:0002174) | 1.46146184 |
| 129 | Menstrual irregularities (HP:0000858) | 1.44496907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.96053441 |
| 2 | CAMKK2 | 3.95111373 |
| 3 | EPHA4 | 3.45949806 |
| 4 | MAP3K9 | 3.26549641 |
| 5 | RIPK1 | 3.16821422 |
| 6 | CAMKK1 | 3.03403178 |
| 7 | DAPK2 | 2.76299136 |
| 8 | MAP3K4 | 2.57130090 |
| 9 | RIPK4 | 2.33403616 |
| 10 | MINK1 | 2.33253535 |
| 11 | STK38 | 2.22106880 |
| 12 | NTRK2 | 2.16451182 |
| 13 | WNK1 | 2.14137477 |
| 14 | PAK6 | 2.09579571 |
| 15 | MAP2K7 | 1.82393254 |
| 16 | MAP2K4 | 1.80480484 |
| 17 | CDK19 | 1.78589339 |
| 18 | PRKD3 | 1.71219318 |
| 19 | KSR2 | 1.67222722 |
| 20 | PRPF4B | 1.65380059 |
| 21 | TYRO3 | 1.51793895 |
| 22 | NTRK1 | 1.51462907 |
| 23 | TNIK | 1.47935524 |
| 24 | MARK1 | 1.44012717 |
| 25 | CDK5 | 1.38474283 |
| 26 | JAK1 | 1.36931496 |
| 27 | PINK1 | 1.36899363 |
| 28 | SGK2 | 1.35633582 |
| 29 | DAPK1 | 1.33628470 |
| 30 | SGK3 | 1.32294914 |
| 31 | SGK494 | 1.28973678 |
| 32 | SGK223 | 1.28973678 |
| 33 | CAMK1 | 1.28858347 |
| 34 | PRKCG | 1.25430983 |
| 35 | STK11 | 1.24260850 |
| 36 | FES | 1.23954212 |
| 37 | MAPK12 | 1.22380323 |
| 38 | PRKCH | 1.21755190 |
| 39 | AKT3 | 1.20491012 |
| 40 | SIK2 | 1.18384016 |
| 41 | EEF2K | 1.15232143 |
| 42 | CAMK1D | 1.12980236 |
| 43 | KSR1 | 1.12221642 |
| 44 | OXSR1 | 1.10612348 |
| 45 | MAP3K13 | 1.10264845 |
| 46 | ALK | 1.09633834 |
| 47 | CDK12 | 1.07569774 |
| 48 | CAMK4 | 1.04802942 |
| 49 | UHMK1 | 1.00744163 |
| 50 | PDK1 | 0.94752424 |
| 51 | MAP3K2 | 0.93172944 |
| 52 | RET | 0.89048856 |
| 53 | TAOK1 | 0.88914773 |
| 54 | GRK5 | 0.88081028 |
| 55 | SGK1 | 0.86473452 |
| 56 | CAMK1G | 0.86401884 |
| 57 | PNCK | 0.86332432 |
| 58 | CAMK2B | 0.85438791 |
| 59 | CDK15 | 0.84992401 |
| 60 | SYK | 0.84020689 |
| 61 | PDPK1 | 0.82455553 |
| 62 | CDK18 | 0.81953867 |
| 63 | CDC42BPA | 0.80766933 |
| 64 | CAMK2G | 0.76591497 |
| 65 | PDK2 | 0.76544253 |
| 66 | MARK2 | 0.74639641 |
| 67 | CAMK2A | 0.74465346 |
| 68 | CDK11A | 0.73130337 |
| 69 | ITK | 0.72030994 |
| 70 | FGFR3 | 0.71156134 |
| 71 | LATS2 | 0.70254162 |
| 72 | BLK | 0.69545787 |
| 73 | CDK14 | 0.69397146 |
| 74 | MAPK13 | 0.68436854 |
| 75 | TNK2 | 0.67619815 |
| 76 | PHKG1 | 0.67487788 |
| 77 | PHKG2 | 0.67487788 |
| 78 | BMPR2 | 0.66898749 |
| 79 | BRAF | 0.66323568 |
| 80 | MYLK | 0.63743337 |
| 81 | JAK2 | 0.63389581 |
| 82 | NEK6 | 0.62050176 |
| 83 | DYRK1A | 0.61897167 |
| 84 | SCYL2 | 0.60135870 |
| 85 | * RPS6KA3 | 0.59554982 |
| 86 | CAMK2D | 0.57782957 |
| 87 | MAPK7 | 0.57280761 |
| 88 | PRKG2 | 0.56209867 |
| 89 | MAPKAPK5 | 0.54215430 |
| 90 | RAF1 | 0.53986840 |
| 91 | FER | 0.53427560 |
| 92 | PTK6 | 0.53127821 |
| 93 | MAP3K14 | 0.53121822 |
| 94 | CSNK1G2 | 0.52912747 |
| 95 | ARAF | 0.52289191 |
| 96 | HIPK2 | 0.51938418 |
| 97 | LMTK2 | 0.51828203 |
| 98 | TRIB3 | 0.51208449 |
| 99 | PRKD2 | 0.49756217 |
| 100 | RPS6KB1 | 0.49545765 |
| 101 | PLK2 | 0.49289483 |
| 102 | TRPM7 | 0.49083107 |
| 103 | CSNK1A1L | 0.47629149 |
| 104 | MOS | 0.47410854 |
| 105 | MAP3K7 | 0.47197196 |
| 106 | MAPK10 | 0.47053991 |
| 107 | MAP3K12 | 0.45649933 |
| 108 | CDK3 | 0.45263174 |
| 109 | PTK2B | 0.45092806 |
| 110 | MAP3K1 | 0.43920424 |
| 111 | CASK | 0.43338447 |
| 112 | DMPK | 0.42547926 |
| 113 | * FYN | 0.42163521 |
| 114 | PDGFRA | 0.42050728 |
| 115 | MAPK11 | 0.41684285 |
| 116 | ROCK2 | 0.40849655 |
| 117 | BTK | 0.40154079 |
| 118 | PTK2 | 0.39269409 |
| 119 | WNK3 | 0.38681280 |
| 120 | FGFR2 | 0.38518940 |
| 121 | BMX | 0.38270281 |
| 122 | MAPK4 | 0.37978191 |
| 123 | * PRKG1 | 0.36974763 |
| 124 | MTOR | 0.36936139 |
| 125 | PRKCZ | 0.35618051 |
| 126 | LCK | 0.35217138 |
| 127 | MAP2K1 | 0.32766272 |
| 128 | PRKCA | 0.32606874 |
| 129 | MAP4K1 | 0.32582466 |
| 130 | PRKCB | 0.32474747 |
| 131 | SRC | 0.32419951 |
| 132 | ICK | 0.31754571 |
| 133 | DAPK3 | 0.30889247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.02913707 |
| 2 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.91989364 |
| 3 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.82331085 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72433617 |
| 5 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.69336800 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66945711 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.66863467 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.61596385 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43880493 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.38058465 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.25047379 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.17787688 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.15249638 |
| 14 | * Long-term depression_Homo sapiens_hsa04730 | 2.10944574 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.10767271 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.93681144 |
| 17 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.92922120 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.87746632 |
| 19 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87067784 |
| 20 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.84310683 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72918182 |
| 22 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.70090050 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.69501054 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.56603407 |
| 25 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56343900 |
| 26 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55474908 |
| 27 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.49485350 |
| 28 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.46239746 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45020127 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40257486 |
| 31 | * Renin secretion_Homo sapiens_hsa04924 | 1.27534573 |
| 32 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22060974 |
| 33 | * Gap junction_Homo sapiens_hsa04540 | 1.15846150 |
| 34 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11817524 |
| 35 | * Pancreatic secretion_Homo sapiens_hsa04972 | 1.11723989 |
| 36 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10877675 |
| 37 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.09943909 |
| 38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06537435 |
| 39 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05647629 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01250915 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.00544825 |
| 42 | Glioma_Homo sapiens_hsa05214 | 0.95530215 |
| 43 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94218159 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92082604 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 0.92011888 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90709792 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89357971 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86300559 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83795454 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82937501 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82208366 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80041838 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77282824 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77103245 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76932229 |
| 56 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76922514 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75912576 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72805693 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72121656 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72070067 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71538705 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67970438 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67485251 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67482949 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63819570 |
| 66 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.63119189 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61519700 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59400242 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59074555 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58942105 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.57296227 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.55548554 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54882088 |
| 74 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54682406 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51876002 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51432862 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51243679 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50964144 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49701172 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49329894 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48359896 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47496377 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47430631 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46757872 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44768396 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44544470 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.43210182 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41401019 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41381347 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40639075 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39425325 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38807831 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.38317194 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37719574 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37391060 |
| 96 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37320874 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.37296990 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.37243117 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36603627 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.34722229 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33692819 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33433454 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33136655 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32930281 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31742329 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31574592 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31167927 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30262012 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29319304 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29178579 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28886711 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28833671 |
| 113 | * Platelet activation_Homo sapiens_hsa04611 | 0.28455090 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28258962 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28038112 |
| 116 | Leishmaniasis_Homo sapiens_hsa05140 | 0.24960257 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24037307 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23110550 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22789471 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22551202 |

